Bio-Rad Laboratories has reported strong growth in the last quarter
of 2007, with a 34 per cent increase in revenue compared to the
last quarter of 2006. These results have contributed to an overall
14.7 per cent increase in sales...
The globalisation of the supply chain increasingly challenges the
US Food and Drug Administration's ability to ensure the quality of
pharmaceuticals on the US market, acknowledges the acting director
of the agency's Center...
Dutch biotech Pharming has solidified its patent position in the
use of transgenic cattle to produce protein therapeutics through a
licence agreement with Advanced Cell Technology (ACT), a US company
developing stem cell therapies...
Applera has announced its intentions to separate its Celera Group
from the Applera Corporation, forming a separate, publicly-traded
company, subject to approval from the US Securities and Exchange
Commission and Applera's board...
Asia has been dubbed the "land of golden opportunities" by
PricewaterhouseCoopers (PWC), who says it is poised to become the
largest pharmaceutical consumer and producer in the world.
German chemicals giant BASF has announced its latest brace of price
rises, this time for two forms of carboxylic acid and for bleaching
and reducing agents.
Life sciences systems maker Bruker Corp reported
stronger-than-expected fourth-quarter earnings and revenue results
on the back of the company's recent $1.1bn acquisition of
affiliated firm Bruker BioSpin.
With active pharmaceutical ingredient sales of $1,460m (€960.8m) in
2007 and a portfolio of more than 250 compounds, Teva
Pharmaceutical Industries is by a long stretch the dominant
supplier in the global API market.
A long-acting injectable formulation of Eli Lilly's blockbuster
schizophrenia treatment Zyprexa (olanzapine), with the potential to
improve patient adherence and take some of the sting out of generic
competition three years down...
A UK chemicals plant has become the latest casualty of
GlaxoSmithKline's (GSK's) pledge to make the business leaner with
the help of outsourcing and offshoring.
UK specialty pharmaceutical company Glide Pharma has signed a deal
with a "leading" pharmaceutical company, under which the as yet
unidentified firm will evaluate Glide's Solid Dose Injection system
for the administration...
A Polish and a Czech firm have merged together in a bid to
strengthen their position in the Central and Eastern Europe's
(CEE's) budding clinical research scene.
A multinational, multidisciplinary initiative involving scientists,
public health workers, police and government officials could
provide a cogent model for rooting out and stamping out
counterfeiting of essential and lifesaving drugs.
Bosch Packaging Technology will be rolling out a range of new and
recently launched processing and packaging solutions at the
Interpack 2008 exhibition in Düsseldorf, Germany this April,
including a new line for high-potency compounds.
A new consortium in Scotland is to develop a new 3D cell assay for
use in drug discovery and for safety evaluation prior to clinical
trials, in the hope of cutting costs and reducing the use of
animals for testing.
Bayer Healthcare is to deploy a new technique, developed by
Millipore, for genetically engineering cells to produce
pharmaceutically useful proteins that could both increase the yield
and accelerate drug production.
Novartis has lent impetus to the growing trend towards
philanthropic R&D in the pharmaceutical industry by opening a
new research institute in Siena, Italy "with a non-profit
mission to exclusively focus on the development...
Jubilant Organosys, India's largest custom research and
manufacturing services (CRAMS) provider, has scored new contracts
to the tune of $92m for the year thus far as its business continues
to gather momentum.
An investigation in the aftermath of a fire and explosion at one of
Cambrex' US plants last year has found the firm in breach of
several safety regulations and the company will be fined
accordingly.
Biotage has announced plans to shift its business focus to the
environmental analysis sector - an industry on the rise as soaring
world population demands more efficient and safe laboratory
technologies to deal with waste, hazardous...
Accu-Break Pharmaceuticals (ABP), the US company with a suite of
tableting technologies for creating divisible dosage forms, has
signed a co-operation agreement with Germany's Midas Pharma that
should open new avenues for technology...
Japan's Eisai has inked a deal with Accenture to have it provide it
with global clinical data management services from India, and
becomes the first big Japanese pharma firm to take such a step.
Germany's rap.ID Particle Systems has launched a new lab-ready
particle identification device capable of identifying around 400
particles an hour from 5µm and up. The company says the device is
suited for development and quality...
Denmark's Novozymes has renewed and extended its collaboration with
UK-based biotech Upperton Limited on a drug delivery system that
exploits the natural binding properties of recombinant protein
nanoparticles to improve compound...
Europe's Novasecta has formed an alliance with Chinese contract
research organisations (CROs) Sundia Meditech and HD BioSciences to
provide their R&D services to European mid-sized biopharma
firms.
A new recombinant pig liver esterase (PLE) biocatalyst that
sidesteps concerns about the safety of animal-derived versions has
been launched by DSM Pharma Chemicals.
More details have emerged over the US Food and Drug
Administration's (FDA's) failure to vet the Chinese manufacturing
plant implicated in the Baxter heparin scare - the agency mistook
it for an already-inspected plant, it...
A nanoparticle-based delivery system is being developed in the UK
as a potential means of bypassing the blood brain barrier and
improve the treatment of central nervous system diseases such as
brain cancer.
Aceto, the US-based distributor and marketer of fine and industrial
chemicals, is making a determined pitch for the pharmaceutical
intermediates sector in Japan.
A lab on a chip method has been developed to mimic brain
chemistry and so give a greater understanding of how neurons in the
brain interact in the formation of a nervous system.
The UK's Applied Cytometry is gearing up to launch a new ultra
high-speed software system for data analysis/processing in
applications generating large data sets such as laser flow
cytometry.
A novel delivery system that converts the structure of cartilage
"from a barrier into a reservoir" could provide an answer
to the challenge of administering and maintaining drugs in
avascular tissue.
With 40-60 per cent of a global drug manufacturing industry worth
more than $380bn captured by the North American marketplace, the
region offers sustained opportunities for suppliers of
pharmaceutical water and wastewater treatment...
A new 'map' that depicts the interactions between proteins from
pathogens and humans could help explain how viruses and bacteria
manage to trick victim cells into carrying out their dirty work.
The first European approval application for a vaccine delivered via
a new intradermal (ID) microinjection system developed by BD
(Becton, Dickinson & Company) has been filed by Sanofi-Pasteur,
the vaccines division of the Sanofi-Aventis...
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving Global Research
Services, Quintiles and Icon.
Novo Nordisk and Merck & Co have both indicated they have their
eye on expanding their drug discovery and manufacturing presence in
India and forging new research partnerships among companies in the
country.
An end may be in sight to the long-running problems with the
Florida manufacturing facility acquired by US brand and generic
company Watson Pharmaceuticals with Andrx Corporation in November
2006.
Questions are hanging over the role of a Chinese manufacturing
facility in the Baxter heparin scare after it has emerged that the
US Food and Drug Administration (FDA) has never inspected the
facility.
A Phase II clinical trial using French company
Polyplus-transfection's innovative gene delivery tool, in
vivo-jetPEI, is set to go ahead this month in Europe and the
US.
UK drug delivery specialist SkyePharma has signed an agreement with
India's Dr Reddy's Laboratories for a feasibility study of an
unnamed product using two of SkyePharma's proprietary drug delivery
systems.
Copapharm Europe, the pan-European alliance of pharmaceutical
packagers, has significantly raised its game in the Spanish market
with a new member, Artes Graficas Nekar.